Galen Partners

New York, New York
Galen Partners is an American VC firm that was founded in 1990 and is currently headquartered in Stanford, Connecticut, USA. The company provides late-stage and early-stage VC funding to innovative startups in the healthcare sector. Since the company was founded just over three decades ago, it has managed a total of three investment funds, with these funds giving the company the capability to make 26 investments. Of these investments, the company has exited from a total of 11 investments.
Founded:1990
Firm Location:New York, New York • Columbus, Ohio • Irving, Texas • Stamford, Connecticut
Galen Partners Team
Photo of Steve Cashman, Investor at Galen Partners
Steve Cashman
Galen Partners·Investor
Sweet spot: $20.0M
Range: $10.0M - $30.0M
Investors in Stamford (CT)
Photo of Michelle Hasson, Venture Partner at Galen Partners
Michelle Hasson
Galen Partners·Venture Partner
Sweet spot: $20.0M
Range: $10.0M - $30.0M
Investors in Stamford (CT)
Investors in Consumer Health (Series B), Investors in Medical Devices (Series B), Investors in Pharmaceuticals (Series B), Investors in Medical Devices (Series A), Investors in Medical Devices (Seed), Investors in Consumer Health (Seed), Investors in Consumer Health (Series A), Investors in Digital Health (Series B), Investors in Pharmaceuticals (Series A), Investors in Pharmaceuticals (Seed), Investors in Health IT (Series B), Investors in Health & Hospital Services (Series B), Investors in Health & Hospital Services (Series A), Investors in Digital Health (Series A), Investors in Digital Health (Seed), Investors in Health IT (Series A), Investors in Health & Hospital Services (Seed), Investors in Health IT (Seed), Investors in Medical Devices (Series B), Investors in Pharmaceuticals (Series B), Investors in Consumer Health (Series B), Investors in Medical Devices (Series A), Investors in Digital Health (Series B), Investors in Medical Devices (Seed), Investors in Pharmaceuticals (Seed), Investors in Pharmaceuticals (Series A), Investors in Health IT (Series B), Investors in Consumer Health (Series A), Investors in Consumer Health (Seed), Investors in Health & Hospital Services (Series B), Investors in Digital Health (Series A), Investors in Boston / New England (Other Lists), Investors in Digital Health (Seed), Investors in Health & Hospital Services (Series A), Investors in Health & Hospital Services (Seed), Investors in Health IT (Series A), Investors in Health IT (Seed), Investors in New York City (Other Lists)
Photo of David Jahns, Managing Director at Galen Partners
David Jahns
Galen Partners·Managing Director
Sweet spot: $20.0M
Range: $10.0M - $30.0M
Investors in Stamford (CT)
Photo of DT Nguyen, Investor at Galen Partners
DT Nguyen
Galen Partners·Investor
Sweet spot: $20.0M
Range: $10.0M - $30.0M
Investors in Stamford (CT)
Investors in Consumer Health (Series B), Investors in Medical Devices (Series B), Investors in Pharmaceuticals (Series B), Investors in Medical Devices (Seed), Investors in Medical Devices (Series A), Investors in Consumer Health (Series A), Investors in Consumer Health (Seed), Investors in Digital Health (Series B), Investors in Pharmaceuticals (Seed), Investors in Health IT (Series B), Investors in Health & Hospital Services (Series B), Investors in Pharmaceuticals (Series A), Investors in Digital Health (Seed), Investors in Digital Health (Series A), Investors in Austin (Other Lists), Investors in Health & Hospital Services (Series A), Investors in Health & Hospital Services (Seed), Investors in Health IT (Series A), Investors in Health IT (Seed), Investors in Medical Devices (Series B), Investors in Pharmaceuticals (Series B), Investors in Consumer Health (Series B), Investors in Boston / New England (Other Lists), Investors in Medical Devices (Series A), Investors in Medical Devices (Seed), Investors in Pharmaceuticals (Series A), Investors in Pharmaceuticals (Seed), Investors in Consumer Health (Series A), Investors in Digital Health (Series B), Investors in Health & Hospital Services (Series B), Investors in Consumer Health (Seed), Investors in Health IT (Series B), Investors in Digital Health (Series A), Investors in Digital Health (Seed), Investors in Health IT (Series A), Investors in Health & Hospital Services (Series A), Investors in Health & Hospital Services (Seed), Investors in Health IT (Seed)
Photo of Zubeen Shroff, Managing Partner at Galen Partners
Zubeen Shroff
Galen Partners·Managing Partner
Sweet spot: $20.0M
Range: $10.0M - $30.0M
Investors in Stamford (CT)
Photo of Michael Simmonds, Vice President at Galen Partners
Michael Simmonds
Galen Partners·Vice President
Sweet spot: $20.0M
Range: $10.0M - $30.0M
Investors in Stamford (CT)
Investors in Consumer Health (Series B), Investors in Medical Devices (Series B), Investors in Pharmaceuticals (Series B), Investors in Medical Devices (Series A), Investors in Medical Devices (Seed), Investors in Consumer Health (Seed), Investors in Consumer Health (Series A), Investors in Digital Health (Series B), Investors in Pharmaceuticals (Seed), Investors in Pharmaceuticals (Series A), Investors in Health IT (Series B), Investors in Health & Hospital Services (Series B), Investors in Health & Hospital Services (Series A), Investors in Digital Health (Series A), Investors in Digital Health (Seed), Investors in Health IT (Series A), Investors in Health & Hospital Services (Seed), Investors in Health IT (Seed), Investors in Medical Devices (Series B), Investors in Consumer Health (Series B), Investors in Pharmaceuticals (Series B), Investors in Medical Devices (Series A), Investors in Medical Devices (Seed), Investors in Pharmaceuticals (Seed), Investors in Pharmaceuticals (Series A), Investors in Health IT (Series B), Investors in Consumer Health (Series A), Investors in Digital Health (Series A), Investors in Digital Health (Series B), Investors in Consumer Health (Seed), Investors in Health & Hospital Services (Series B), Investors in Boston / New England (Other Lists), Investors in Digital Health (Seed), Investors in Health & Hospital Services (Series A), Investors in Health & Hospital Services (Seed), Investors in Health IT (Series A), Investors in Health IT (Seed), Investors in New York City (Other Lists)
Photo of Bruce Wesson, Managing Director at Galen Partners
Bruce Wesson
Galen Partners·Managing Director
Sweet spot: $20.0M
Range: $10.0M - $30.0M
Investors in Stamford (CT)
Photo of L. John Wilkerson, Managing Director at Galen Partners
L. John Wilkerson
Galen Partners·Managing Director
Sweet spot: $20.0M
Range: $10.0M - $30.0M
Investors in Stamford (CT)
Investors in Medical Devices (Series A), Investors in Medical Devices (Seed), Investors in Medical Devices (Series B), Investors in Consumer Health (Series B), Investors in Pharmaceuticals (Series B), Investors in Consumer Health (Series A), Investors in Pharmaceuticals (Series A), Investors in Pharmaceuticals (Seed), Investors in Digital Health (Series B), Investors in Consumer Health (Seed), Investors in Health IT (Series B), Investors in Health & Hospital Services (Series B), Investors in Medical Devices (Series B), Investors in Digital Health (Series A), Investors in Digital Health (Seed), Investors in Pharmaceuticals (Series B), Investors in Health IT (Series A), Investors in Health & Hospital Services (Series A), Investors in Health & Hospital Services (Seed), Investors in Health IT (Seed), Investors in Medical Devices (Series A), Investors in Consumer Health (Series B), Investors in Medical Devices (Seed), Investors in Pharmaceuticals (Seed), Investors in Pharmaceuticals (Series A), Investors in Consumer Health (Series A), Investors in Health & Hospital Services (Series B), Investors in Digital Health (Series B), Investors in Digital Health (Seed), Investors in Health IT (Series B), Investors in Consumer Health (Seed), Investors in Digital Health (Series A), Investors in Boston / New England (Other Lists), Investors in Health IT (Series A), Investors in Health & Hospital Services (Series A), Investors in Health & Hospital Services (Seed), Investors in Health IT (Seed), Investors in New York City (Other Lists)